Tenofovir detection assay
US10768185B2 · kind B2 · utility
5Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2018 |
| Grant date | Sep 8, 2020 |
| Priority date | — |
| Expiry date | Jul 20, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/54388
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein are antibodies capable of specifically binding to tenofovir (TFV), a key small molecule drug for both the treatment and prevention of HIV, and a competitive lateral flow assay that uses these antibodies to monitor urine samples for the presence of the drug. The assay can be deployed as a point-of-care device for adherence monitoring.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.